Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-009490
Filing Date
2022-05-27
Accepted
2022-05-27 17:00:17
Documents
19
Period of Report
2022-07-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A apre-20220728xpre14a.htm PRE 14A 1366308
2 GRAPHIC apre-20220728xpre14a008.jpg GRAPHIC 1032
3 GRAPHIC apre-20220728xpre14a013.jpg GRAPHIC 997
4 GRAPHIC apre-20220728xpre14a011.jpg GRAPHIC 899
5 GRAPHIC apre-20220728xpre14a012.jpg GRAPHIC 1069
6 GRAPHIC apre-20220728xpre14a001.jpg GRAPHIC 5724
7 GRAPHIC apre-20220728xpre14a026.jpg GRAPHIC 150370
8 GRAPHIC apre-20220728xpre14a009.jpg GRAPHIC 980
9 GRAPHIC apre-20220728xpre14a007.jpg GRAPHIC 1012
10 GRAPHIC apre-20220728xpre14a016.jpg GRAPHIC 1023
11 GRAPHIC apre-20220728xpre14a025.jpg GRAPHIC 150962
12 GRAPHIC apre-20220728xpre14a010.jpg GRAPHIC 1041
13 GRAPHIC apre-20220728xpre14a006.jpg GRAPHIC 2625
14 GRAPHIC apre-20220728xpre14a018.jpg GRAPHIC 36494
15 GRAPHIC apre-20220728xpre14a004.jpg GRAPHIC 2788
16 GRAPHIC apre-20220728xpre14a014.jpg GRAPHIC 1072
17 GRAPHIC apre-20220728xpre14a015.jpg GRAPHIC 982
18 GRAPHIC apre-20220728xpre14a005.jpg GRAPHIC 2746
19 GRAPHIC apre-20220728xpre14a017.jpg GRAPHIC 998
  Complete submission text file 0001558370-22-009490.txt   1869940
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39069 | Film No.: 22978664
SIC: 2834 Pharmaceutical Preparations